Table 1.
Baseline characteristics of participants in the EPIC-Norfolk, LOLIPOP, and FHS study samples
| EPIC-Norfolk, discovery phase | LOLIPOP, confirmation phase | FHS, confirmation phase | ||||
|---|---|---|---|---|---|---|
| Incident T2DM | Noncase | Incident T2DM | Noncase | Prevalent T2DM | Noncase | |
| N | 563 | 701 | 1,074 | 1,590 | 403 | 2,204 |
| Female sex, n (%) | 474 (84) | 407 (58) | 352 (36.3) | 507 (31.8) | 173 (43.0) | 1,245 (56.5) |
| Age (years) | 61.6 (8.1) | 59.1 (9.2) | 52.5 (10.2) | 49.9 (9.8) | 69.3 (8.4) | 65.8 (8.9) |
| Ethnicity | European | European | Indian Asian | Indian Asian | European | European |
| HbA1c (%) | 6.5 (1.3) | 5.5 (0.33) | 5.77 (0.49) | 5.37 (0.48) | 6.67 (1.15) | 5.55 (0.27) |
| HbA1c (mmol/mol) | 47.4 (14.2) | 36.2 (3.6) | 40 (5.4) | 35 (5.2) | 49 (12.6) | 37 (3) |
| BMI (kg/m2) | 29.2 (4.5) | 25.6 (3.6) | 28.9 (4.6) | 26.7 (3.9) | 31.6 (6.2) | 27.7 (5.0) |
Data are means (SD) unless otherwise indicated.